secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immix Biopharma, Inc. (IMMX)
CIK:        0001873835
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001493152-25-012804
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immix Biopharma raises $9.1M in PIPE; Nancy Chang appointed to board
--------------------------------------------------------------------

- Sold 3,831,216 shares at $2.37/share and warrants for 2,873,417 shares at $2.00/share.
- Gross proceeds ~$9.1M for working capital and general corporate purposes; closed on Sept 5, 2025.
- Warrants are non-transferable, exercisable for 10 years, and only for cash.
- Nancy Chang, Ph.D. appointed to board effective Sept 8, 2025; co-founded Tanox (XOLAIR developer).
- Resale registration statement to be filed with SEC within 30 days of closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/0001493152-25-012804-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873835/000149315225012804/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012804

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer